Circular RNAs (circRNAs) are a large type of noncoding RNAs characterized by their circular shape resulting from covalently closed continuous loops. They are known to regulate gene expression in mammals. These tissue-specific transcripts are largely generated from exonic or intronic sequences of their host genes. Although several models of circRNA biogenesis have been proposed, the understanding of their origin is far from complete. Unlike other noncoding RNAs, circRNAs are widely expressed, highly conserved and stable in cytoplasm, which confer special functionalities to them. They are known to serve as microRNA (miRNA) sponges, regulators of alternative splicing, transcription factors and encode for proteins. The expression of circRNAs is associated with several pathological states and may potentially serve as novel diagnostic or predictive biomarkers. CircRNAs are known to regulate the expression of numerous cancer-related miRNAs. The circRNA-miRNA-mRNA axis is a known regulatory pattern of several cancer-associated pathways, with both agonist and antagonist effects on carcinogenesis. In consideration of their potential clinical relevance, circRNAs are at the center of ongoing research initiatives on cancer prevention and treatment. In this review, we discuss the current understanding of circRNAs and the prospects for their potential clinical application in the management of cancer patients. who is interested in the study of regulatory functions of noncoding RNAs. Qin Ma is an assistant professor in Bioinformatics and computational systems biology at South Dakota State University. Shuangchun Ren is an MD student
Introduction
Circular RNAs (circRNAs) are special endogenous noncoding RNAs. Unlike normal linear RNAs, their 3 0 and 5 0 ends are joined together to form covalently closed loop structures, which makes them more conserved and stable [1] . CircRNAs were first discovered in viroids in as early as 1976, and their presence in viruses and eukaryotic cells was later detected in the subsequent decades [2] [3] [4] [5] [6] [7] [8] . CircRNAs were initially thought to result from a failure of alternative splicing owing to their low expression levels [9] . However, with the advent of next-generation sequencing technologies and advances in bioinformatics, the regulatory function of circRNAs in eukaryotic cells is well acknowledged [10] [11] [12] [13] [14] [15] [16] [17] [18] .
Recent studies have shown that the formation of circRNAs could be regulated by inverted repeats of ALU pairs, exons skipping, RNA-binding proteins and other factors [19] [20] [21] [22] [23] [24] . The involvement of circRNAs in the modulation of gene expression is thought to be involved in several pathogenic states [1, 12, 25] , including carcinogenesis [26] [27] [28] [29] [30] . In addition to their potential effect in modulating cancer progression or response to therapy, circRNAs may potentially be of relevance as clinical biomarkers and therapeutic targets in cancer [31] [32] [33] .
In this review, we briefly discuss the diversity, biogenesis, characteristics and potential functions of circRNAs, and the modes of how circRNAs affect carcinogenesis.
Is circRNAs biogenesis an accident in pre-mRNA alternative splicing?
Although circRNAs were initially thought to be a product of alternative splicing errors, the recent advances in deep RNA-sequencing technologies and computational analyses have revealed that they are abundant, conserved and stable [9, 34] . Most eukaryotic circRNAs are generated during alternative splicing, an essential step in the eukaryotic gene expression process that is catalyzed by either spliceosomal machinery or group I/II ribozymes [34] [35] [36] . During splicing, the remnants of noncoding intronic or skipped exonic sequences are released as lariat or linear fragments, which often acquire some special functions. Further, the lariat structures of circRNAs determine the fate of these transcripts that escape from the shearing action of exonucleases and remain stable in cells [24, 34] . The underlying mechanisms of circRNA generation are yet to be clearly understood. However, based on current knowledge, at least three distinct paths have been envisaged [13, 14, 37, 38] .
Any intronic reverse complementary motifs can potentially bring the exons close together and promote the circularization through alternative 5 0 to 3 0 splicing of nascent transcripts. In addition, circRNAs can also be generated from a lariat precursor model that contains skipped exons [13, 20, 38, 39] . Notably, specific to 'Intron-Pairing-Driven Circularization Path' ( Figure 1A ), complementary motifs are necessary to bring the donor-acceptor pairs into apposition for circularization, and exon-skipping event may not occur during this process. The circularization of circRNAs can be promoted by the base pairing between reverse complementary motifs within introns, which depend on a consensus motif containing a seven-nucleotide GU-rich element near the 5 0 splice site, and an 11-nucleotide C-rich element close to the branch point site. The 3 0 splice acceptor (SA) of the skipped exon then attacks 5 0 splice donor (SD), and finally generates a circularized exon (identified as backsplicing) [1, 37, 40] .
For 'Lariat-Driven Circularization Path' ( Figure 1B) , it is the exon-skipping event that leads to the generation of the lariat precursor, and which represents a key attribute of this model. In addition, the order of splicing events, the attack of SD 5 0 site and the need for SA 3 0 site are thought to vary in these two main mechanisms [13] . The importance of ALU complementary flanking elements repeated in intronic regions, which likely triggers the circularization by reverse complementary matches, is consistent with both models [13, 21, 37] . In several gene loci (including ZKSCAN1, HIP3K and EPHB4), the circularized transcripts are flanked by several ALU complementary elements that compete with canonical linear-RNA splicing [13, 41] . Although ALU complementary elements trigger the formation of circRNAs, it is the inverted repeat sequences that are necessary for circularization [20] .
In addition, RNA binding proteins (RBPs) have also been shown to induce the biogenesis of circRNAs. Similar to 'Intron-Pairing Driven Circularization Model', RBPs were shown to specifically bind with the flanking intronic motifs and promote the circle formation at the junction owing to the interaction among bound RBPs that bring the donor-acceptor sequences in proximity to each other, instead of direct base pairing between complementary motifs [1, 21, 35] ( Figure 1C ). Specifically, RBPs can also regulate circRNA formation by either stabilizing the splicing motifs or by inhibiting canonical linear splicing. The alternative-splicing factor RBP Quaking (QKI) was recently shown to modulate circRNA generation during the human epithelial-mesenchymal transition (EMT) [22] . Besides QKI, RBP Muscleblind (MBL) is another protein that was shown to bind to flanking introns of linear pre-circMbl, which triggered the circulation of circMbl [21] . While some RBPs inhibit circRNA formation (e.g. ADAR1), an RNA-editing enzyme can bind to double-stranded RNA to inhibit biogenesis of circRNAs by melting the stem structure [1, 37] .
In brief, the mechanism of circRNA biogenesis is yet to be fully elucidated, although several models have been proposed. Definitive explanation of how these factors control the circRNA circulation and whether they enhance or inhibit the circRNA formation is not clear.
Novel biological functions of circRNAs
Why would the earlier discovered circRNAs regain so much attention now? Recent systemic deep RNA sequencing studies have demonstrated the covalently closed loop structures of circRNAs, which serves to confer RNase resistant properties, and renders them much more stable than endogenous linear RNAs. In Figure 1 . Models of circRNA formation. A. In the 'Intron-Driven Circulation Path', the exon-skipping event is not necessary. It is the intronic reverse complementary motifs that bring the exons close together and promote the circularization. B. In the 'Lariat-Driven Circulation Path', the exon-skipping event during canonical linear alternative splicing generates a lariat structure, which promotes circularization. C. As in the 'Intron-Driven Circulation Path', several circularization processes are triggered by RBPs, which bind to specific targets in introns instead of to the intronic reverse complementary motifs. RBPs, RNA binding proteins. addition, these abundantly expressed molecules are now known to be evolutionarily conserved across different species. Further, unlike other kinds of noncoding RNAs, a small percentage of exogenous circRNAs are translated into some special proteins, as is observed in the case of Hepatitis d virus (HDV). Hence, circRNAs may, for instance, serve as microRNA (miRNA) sponges, or as alternative splicing regulators or transcription factors.
CircRNAs function as miRNA sponges
MiRNAs are pivotal regulators of gene expression at the posttranscriptional level. These act by binding to target sites within messenger RNAs (mRNAs) based on the principle of complementary base pairing [42, 43] . Recently, the regulatory capacity of miRNA was reported as being affected by a special kind of transcript with circular structures. CircRNAs compete for binding to miRNAs, thereby, indirectly modulating the gene expression ( Figure 2A ). Recent accumulated evidence suggests that circRNAs may function as miRNA sponges that serve to strengthen miRNA-binding capacity to more than that of any other competing endogenous RNAs (ceRNAs) [25, 44] . CircRNAs, including ciRS-7/CDR1as (circRNA sponge for miR-7/cerebellar degeneration-related protein 1 antisense) and Sry (Murine Sex-determining region Y), have been shown to be devoid of polymorphisms at the miRNA binding sites, and can adsorb miRNAs without being digested by RNA-induced silencing complex (RISC), which renders them as excellent candidates for gene expression regulation [1, 14, 45] .
Specifically, the exonic ciRS-7/CDR1as, which was the first studied for its functions of circRNA, is conserved across species. More than 70 miR-7 conventional seed-targets with non-perfect complementarity have been identified within ciRS-7/CDR1as. By adsorbing miR-7, ciRS-7/CDR1as would effectively reduce the regulatory function of miR-7. The overexpression of ciRS-7/CDR1 would increase the expression level of miR-7 target genes, such as SNCA, EGFR, IGF1R and IRS2 [1, 46, 47] . On the contrary, the expression level of miR-7 target genes would be decreased by silencing of ciRS-7/CDR1 or existence of miR-671 (a special miRNA with ciRS-7/ CDR1as splitting function). Furthermore, ciRS-7/CDR1as has been shown to have a high expression in nervous tissues of all eutherian mammals [25] . Sry can produce a testis-specific single-exonic circRNA that similarly harbors 16 binding targets for miR-138. When co-transfected with pJEBB-128 (miR-138 expression vector), it can get co-precipitated with Argonaute 2 (AGO2). This suggests that circular Sry may also serve as an miRNA sponge specific for miR-138 [25, 48] . Similarly, several miRNA binding sites have been identified in both cir-ITCH and 3 0 -untranslated regions (3 0 -UTR) of canonical ITCH transcripts. cir-ITCH was also shown to induce the expression of ITCH by binding with three miRNAs including miR-7, miR-17 and miR-214 [28] . However, on examining a large set of exonic circRNAs identified by CircleSeq, few circRNAs in mammalian cells were found to contain more than 10 binding sites for an individual miRNA. Furthermore, many exonic circRNAs contain only small numbers of putative miRNA binding sites. Therefore, whether circular miRNA sponges represent a general phenomenon, and the underlying mechanism by which networks of circRNAs, miRNAs and ceRNAs interact to maintain cellular homeostasis, remains to be clarified [1] .
CircRNAs function as alterative splicing regulators or transcription factors
Although the sponge functions of circRNAs have been the most widely studied, several other potential functions have also been identified in recent studies. Some studies have suggested that circRNAs may also function as alternative splicing regulators or transcription factors (Figure 2B, C) . For instance, circMbl (circular muscleblind), a circRNA circularized from the second exon (containing a start codon of main coding sequence) of the splicing factor muscleblind (MBL/MBNL1), has been shown to strongly compete with canonical splicing. Within circMbl, MBL-specific binding motifs have been identified and observed to be highly conserved across species. Modulation of MBL levels may also strongly affect the circMbl biosynthesis that depends on MBL binding sites [21] . Besides, many other circRNAs have been shown to contain translation-initiating site and could potentially compete with pre-mRNA splicing of their host genes. In summary, circRNAs may potentially be used as mRNA traps, by segregating start codon to regulate gene expression [1, 14, 49] .
Exon-intron circRNAs (EIciRNAs), a novel subtype of circRNA, have been shown to function as transcription factors. Within the promoter region of their host gene, EIciRNAs were shown to associate with RNA Polymerase II and U1 small nuclear ribonucleic proteins (snRNPs) through an intact splice donor, and thereby, decrease the mRNA transcription status of the host gene. Thus, these nuclear circRNAs have the potential to regulate the expression of their host gene dependent on U1 snRNPs in cis [17, 50] . Furthermore, during functional characterization of stable lariat molecules, the potential of U1 snRNPs to regulate the expression of genes located at other genomic loci in trans has also been observed. Stable lariat molecules are known to modulate gene expression when in the cis form. Therefore, these two distinct RNAs with circular structures may function in the same regulatory milieu.
Other potential functions of circRNAs
Besides adsorbing miRNAs like sponges and competing with canonical splicing, several circRNAs can encode proteins with functions distinct from their linear transcripts ( Figure 2D ). An engineered circRNA containing an internal ribosomal entry site, the eukaryotic ribosomal 40S subunits were shown to bind to circRNA at the entry point and initiate the translation, both in vitro and in vivo [16, 45, 51] .
Similarly, in Escherichia coli, green fluorescent protein (GFP) can be translated by transfecting an artificial circRNA inserted with a GFP open reading frame [16, 52] . So far, however, only viral circRNA is known to encode proteins in eukaryotic cells. For instance, HDV, a subviral satellite of hepatitis B virus (HBV), viral proteins specific to pathogenicity were shown to translate in host cells while being co-infected with HBV [6, [53] [54] [55] . Translation of viral circRNAs is probably related to specific viral agents, although there is no direct evidence till date to suggest that natural eukaryotic endogenous circRNAs can be translated. Some prokaryotic circRNAs may have the potential to function as templates for translation, and indicated by the efficient translation of pure synthetic transcripts of these circRNAs.
In addition, whether the covalently closed circular structures of circRNAs are essential for their regulatory potential, and whether they are only protective against exonucleolytic digestion, needs to be confirmed. Given the number of circRNAs with incomplete functional characterization, the potential existence of other hitherto unknown circRNAs or functional RNAs, which may have been missed in the previous studies, cannot be ruled out.
CircRNAs are small molecules with immense potential in cancer both carcinogenesis and cancer progression. CircRNAs may be involved in regulation of cancer-related pathways and appear promising as novel diagnostic or therapeutic biomarkers. More details can be found below.
CircRNAs regulate cancer-related biological processes
MiRNAs are known to regulate gene expression in most biological processes, including in carcinogenesis. Given the miRNA sponge function, circRNAs are thought to affect the activity of cancer-related miRNAs via regulation of the expression levels of their target genes.
As mentioned previously, the newly identified ciRS-7 can efficiently harbor miR-7, which is known to be involved in many cancer-associated pathways. The current body of evidence suggests that miR-7 regulates cellular functions linked to tumorigenesis by downregulation of major oncogenic factors such as ACK1 [56] , MRP1/ABCC1 [57] , BCL2 [58] , EGFR [59] [60] [61] , FAK [62, 63] , HER2D16 [64] , KLF4 [65] [66] [67] , IGF1R [47, 68] , IRS-1/2 [46] , mTOR [69] , PA28c [70] , PAK1 [56] , PAX6 [71, 72] , PIK3CD [69] , RAF-1 [60] , REGc [73] , SETDB1 [74] , XIAP [75] and YY1 [76] . For example, miR-7 was shown to suppress the epithelial to mesenchymal transition (EMT) by upregulating E-cadherin indirectly by targeting FAK and IGF1R [47, 62, 63, 68] . Further, by downregulation of KLF4/ PI3K/Akt/p21 pathway, the stem cell-like morphology of prostate cancer cells was found to be attenuated, which was indicative of tumor suppression [77] . In vitro, malignant phenotypes of non-small-cell lung cancer cell lines can be suppressed by inhibiting the action of miR-7 targeting PAX6 [71] . In human cancer cells, the inhibition of miR-7 was shown to suppress cellular proliferation and trigger apoptosis, which indicates dual effect of miR-7 expression on carcinogenesis [78] .
Currently available evidence suggests that homeostasis of this apparently bifunctional molecule may be instrumental in modulating the complex regulatory patterns that may trigger or suppress carcinogenesis, depending on their expression levels. Being miRNA sponge for miR-7, ciRS-7 could completely resist the miR-7-derived RNA destabilization by controlling miR-7 activity and, thereby, exert a regulatory effect on cancer-related biological pathways. ciRS-7 can tightly conjugate with AGO proteins, the catalytic core of RISC, by tethering with miR-7. Thus, regulating the content of free miR-7, ciRS-7/miR-7 complexes may also serve to maintain or disturb the homeostasis by significantly affecting the available RISC components in cells. Furthermore, miR-671 has been shown to act as a circRNA inhibitor that can bind and degrade ciRS-7 in cells. Consequently, the fine-tuning of the balance among miR-7/ciRS-7/miR-671 axis in cancer cells may influence the progression of cancer.
CircRNAs are promising biomarkers for cancer diagnosis and therapy
The clinical potential for use of circRNAs as diagnostic and therapeutic biomarkers for cancers is increasingly being investigated. Downregulation of hsa_circ_002059 in gastric cancer was shown to be significantly associated with the TNM stage and distant metastasis, which indicated its potential as a novel biomarker for the diagnosis and progression of gastric cancer [32] . Exosomes, secreted by most cells, are small transporters of ribonucleases and a wide variety of RNA species, which are thought to modulate behavior of cancer cells. It is another potential candidate for a diagnostic and therapeutic biomarker for cancers [30, [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] .
A previous study found that exosomes are enriched with stable circRNA, thus making it a promising biomarker for cancer diagnosis. In that study, researchers found circRNAs were at least 2-fold enriched in the exosomes secreted from cancer cells, and was moderately associated with cellular circRNAs. When compared with the content of linear RNAs detected in the human blood, circRNAs were found to be more stable than linear RNAs and retained their stability in serum samples for at least 24 h at room temperature. Similar phenomenon has been observed in colon, lung, stomach, breast and cervical cancer cell lines [33] .
Summary
In general, circRNAs appear to serve a plethora of regulatory functions. Based on RNA-sequencing, circRNA microarray, target prediction, interaction prediction, structure prediction, bioinformatics analysis and experimental studies, including fluorescence in situ hybridization, RNA immunoprecipitation, AGO immunoprecipitation and luciferase reporter assay, circRNAs have been identified as miRNA sponges, alternativesplicing regulators, transcription factors and even protein encoding special RNAs. By controlling the expression of cancerrelated genes, circRNAs are involved in the modulation of cancer cell growth, proliferation, invasion and metastasis. CircRNAs represent potential candidates for serving as clinical diagnostic biomarkers and therapeutic targets for cancer.
